Threshold Starts Glufosfamide Phase III In Pancreatic Cancer Sep. 14, 2004 By Aaron Lorenzo No Comments
Life Sciences Firm Serologicals To Buy Upstate For $205 Million Sep. 9, 2004 By Aaron Lorenzo No Comments Serologicals Corp. is paying $205 million to grow its business through the acquisition of Upstate Group Inc. (BioWorld Today)Read More
Life Sciences Firm Serologicals To Buy Upstate For $205 Million Sep. 9, 2004 By Aaron Lorenzo No Comments Serologicals Corp. is paying $205 million to grow its business through the acquisition of Upstate Group Inc. (BioWorld Today)Read More
Deal With Merck Potentially Worth $26M For TransTech Sep. 8, 2004 By Aaron Lorenzo No Comments TransTech Pharma Inc. secured another partnership, courtesy of its platform technology, in a collaboration that could be worth at least $26 million to the 5-year-old firm. (BioWorld Today)Read More
